Skip to Main Content

Paper Details

Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies.
Cell Syst
37
2018
Author NameAffiliation
Peng JiangDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Peng JiangDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Myles BrownDana-Farber Cancer Institute and Harvard Medical School, USA Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Xiaole Shirley LiuDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Tongji University, Harvard University, USA Center for Functional Cancer Epigenetics
  • 1 - 4

Datasets

Release 1.2